Discoveries
navigating the future
of biologics
Welcome to Discoveries at Bora Biologics, your destination for the latest insights and knowledge to keep you at the forefront of biopharmaceutical innovation. Here, you’ll find a curated collection of educational resources—press releases, expert insights, case studies, and publications—crafted to inspire and inform you on your journey from molecule to market.


What’s New at Bora Biologics
Publications
Scaling Analytical RP-HPLC to Semi-Preparative for Fractionation and Characterization of Pegfilgrastim Oxidized Variants
Publications
Characterization of Product Related Variants in Therapeutic Monoclonal Antibodies
Publications
Analysis of Therapeutic Monoclonal Antibodies Using a Platform Size Exclusion-HPLC Method
Publications
Dimethyl Sulfoxide as a Gas Phase Charge-reducing Agent for the Determination of PEGylated Proteins’ Intact Mass
Publications
Comparative Analysis of Herceptin N-Linked Glycosylation by HILIC-FLD and LC-MS/MS Methods
Publications
Characterization of PEGylation Sites in Neulasta and a Biosimilar Candidate with a Combined Fragmentation Strategy in Mass Spectrometry Analysis







Bora Biologics
the logical choice
Join the ranks of biopharma pioneers who trust us.
Explore how we minimize risks and accelerate your success.
Client-Centric
100% commitment to supporting your success
Experience
14 years developing & manufacturing biologics
Expertise
125 seasoned scientists & regulatory professionals
Commercial-Ready
US FDA registered GMP manufacturing facility
Allied
access to global CDMO resources